Lv4
580 积分 2023-11-28 加入
One Target—Two Different Binding Modes: Structural Insights into Gevokizumab and Canakinumab Interactions to Interleukin-1β
8个月前
已完结
A preclinical and clinical review of aflibercept for the management of cancer
9个月前
已关闭
Gout
10个月前
已完结
Autoimmune diseases and atherosclerotic cardiovascular disease
10个月前
已完结
VEGFA mRNA for regenerative treatment of heart failure
10个月前
已完结
Targeting IL-6 in patients at high cardiovascular risk
10个月前
已完结
Diabetic macular edema: Upcoming therapies
11个月前
已完结
Age-related macular degeneration
11个月前
已完结
Safety and efficacy of apitegromab in nonambulatory type 2 or type 3 spinal muscular atrophy (SAPPHIRE): a phase 3, double-blind, randomised, placebo-controlled trial
11个月前
已完结
Chronic Spontaneous Urticaria
1年前
已完结
皖公网安备34019202002308
